With 8% Growth In May, Is The Indian Market On The Recovery Path?
This article was originally published in The Pink Sheet Daily
Executive Summary
Positive signs are emerging about growth prospects in the $13 billion Indian pharmaceutical market as companies are aligning with the new pricing policy brought into effect last year. But with new threats of price cuts, uncertainties are not ruled out and many multinationals lagged domestic companies.